New Survey: 84% of Respondents Would Participate in a Hospital-at-Home Program In Order To Get Home Sooner

Vivalink’s survey reveals strong consumer support for flexible care models, indicating a need for home based care as part of the national healthcare system

More than 300 Hospital at Home (HaH) programs have been approved across the country, allowing thousands of patients to be monitored in the comfort of their homes after leaving the hospital.

Vivalink, a leading provider of digital healthcare solutions, is sharing results from a new survey of more than 1,000 U.S. consumers 40 years and older about their opinions surrounding participating in a HaH program.

Key findings from the survey include:
  • An overwhelming 84% of respondents are willing to participate in HaH monitoring in order to return home sooner versus staying at the hospital to be monitored. 

  • 77% of respondents indicated that they would trust their healthcare provider’s recommendation to utilize HaH monitoring.

  • Of those who have experienced HaH, 84% reported having a positive experience with the program.

  • 49% of respondents who had participated in a HaH program found the remote patient monitoring (RPM) device easy to use. At the same time, of the 16% of respondents who were not likely to participate in HaH programs, difficulty with devices was cited as a top concern.
The survey also delved into demographic variations, uncovering insights based on age and location:
  • Older respondents (over 70) were less likely to have heard of HaH programs (42% vs. 77% of consumers in their 40s), or had participated in HaH programs (11% vs. 66%).

  • Urban participants were more likely to have participated in HaH programs (71% vs. 25% of rural respondents) but were less likely to prefer completely remote primary care compared to rural participants (19% vs. 36% of rural respondents). 

  • Respondents with three or more hospitalizations in the last 12 months demonstrated a higher willingness to participate in HaH programs (95% vs. 62% of respondents with 2 or fewer hospitalizations) and expressed greater trust in providers’ recommendations for HaH monitoring (95% vs 78%).
The survey’s findings are particularly compelling as the waivers introduced by the Centers for Medicare and Medicaid Services (CMS) in response to the COVID-19 pandemic, which allowed inpatient-level hospital services to be conducted in patients’ homes, are set to expire at the end of this year, emphasizing the need for permanent adoption of flexible care models like HaH programs.

“Consumers are increasingly driving the trend towards receiving care in the comfort of their own homes. This shift, accelerated by the COVID pandemic, underscores the importance of providing flexible and convenient healthcare solutions that meet patients’ evolving needs,” said Jiang Li, CEO of Vivalink. “At Vivalink, we are committed to the development of advanced digital healthcare solutions in order to improve access and efficiency of the healthcare system for all.”

For more details and infographics, click here.

SourceVivalink

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.